0001209191-19-025629.txt : 20190423
0001209191-19-025629.hdr.sgml : 20190423
20190423191216
ACCESSION NUMBER: 0001209191-19-025629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180305
FILED AS OF DATE: 20190423
DATE AS OF CHANGE: 20190423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Motahari Saeed
CENTRAL INDEX KEY: 0001704399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 19762390
MAIL ADDRESS:
STREET 1: C/O INSYS THERAPEUTICS, INC.
STREET 2: 1333 SOUTH SPECTRUM BLVD, SUITE 100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-05
0
0001516479
Insys Therapeutics, Inc.
INSY
0001704399
Motahari Saeed
C/O INSYS THERAPEUTICS, INC.
1333 SOUTH SPECTRUM BLVD, SUITE 100
CHANDLER
AZ
85286
1
1
0
0
President & CEO
Common Stock
2018-03-05
4
A
0
16000
0.00
A
70986
D
Common Stock
2019-01-25
4
A
0
59206
0.00
A
130192
D
Employee Stock Option (right to buy)
8.06
2018-03-05
4
A
0
64000
0.00
A
2028-03-04
Common Stock
64000
64000
D
Employee Stock Option (right to buy)
3.81
2019-01-25
4
A
0
282152
0.00
A
2029-01-24
Common Stock
282152
282152
D
The total reported in Column 5 includes 33,000 RSUs previously reported in Table II on the Form 4 filed 4/20/17. Also includes 2,283 and 4,303 shares acquired by the Reporting Person on 12/8/17 and 6/8/18, respectively, pursuant to the Issuer's Employer Stock Purchase Plan.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023.
/s/ Andrew Long, Attorney-in-fact
2019-04-19